Optical Angiography in Glaucoma
1 other identifier
observational
61
1 country
1
Brief Summary
Glaucoma is one of the leading causes for blindness in industrialized countries. It is characterized by a progressive loss of retinal ganglion cells, morphological changes in the optic nerve head and a characteristic loss of visual field. It has been speculated for a long time that vascular factors may also contribute to the pathogenesis of the disease. This concept has been supported by several epidemiological studies showing that small retinal vessel calibre are associated with the disease. In the recent years tremendous enhancements in the field of optical coherence tomography has been achieved. These developments made it possible to visualize the retinal vasculature in a full depth manner without the application of an intravenous marker. The proposed study tests the hypothesis that patients with glaucoma show altered vascular morphology compared to healthy subjects. This is of importance because it may clarify the degree of vascular involvement in glaucoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2015
CompletedStudy Start
First participant enrolled
September 11, 2015
CompletedFirst Posted
Study publicly available on registry
September 14, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 25, 2016
CompletedApril 7, 2022
April 1, 2022
1.1 years
September 4, 2015
April 6, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Retinal vessel diameter as extracted from the angiograms
during the four weeks after the first screening day
Secondary Outcomes (3)
Systemic hemodynamics (Blood pressure)
during the four weeks after the first screening day
Intraocular pressure
during the four weeks after the first screening day
pulse
during the four weeks after the first screening day
Study Arms (2)
Glaucoma Patients
Patients with primary open angle glaucoma
Healthy controls
age- and sex matched controls
Interventions
This measurement will be obtained after the dilation of the pupil. Optical coherence tomography (OCT) is a non-invasive optical imaging modality enabling cross-sectional tomographic in vivo visualization of internal microstructure in biological systems. In ophthalmology OCT has become a standard device in visualizing the retina and is also considered a standard tool in the diagnosis of retinal disease. In optical angiography blood vessels contrasting against static tissue are visualized in a full depth resolved and label-free manner.
Eligibility Criteria
30 open angle glaucoma patients 30 healthy age- and sex matched controls
You may qualify if:
- Diagnosis of manifest open angle glaucoma as defined as pathological optic disc appearance, glaucoma hemifield test outside normal limits and/or untreated IOP ≥ 21 mmHg on at least three measurements in the medical history. Mean deviation in the visual field test \< 10dB
You may not qualify if:
- Normal ophthalmic findings, IOP ≤ 20mmHg
- No history of elevated IOP
- No signs of glaucomatous disc damage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Vienna
Vienna, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. PD Dr.
Study Record Dates
First Submitted
September 4, 2015
First Posted
September 14, 2015
Study Start
September 11, 2015
Primary Completion
November 1, 2016
Study Completion
November 25, 2016
Last Updated
April 7, 2022
Record last verified: 2022-04